City of Hope Names Renowned Researcher Michael Caligiuri President and Physician-in-Chief

January 5, 2018 | City of Hope

Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.

Continue Reading

City of Hope Researcher Seeks New Cure for Hemophilia

February 21, 2018 | Katie Neith

Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of the Beckman Research Institute at City of Hope, thinks she may know a way to cure hemophilia A.

City of Hope's CEACAM Research Comes Full Circle with New CAR T Approach

February 9, 2018 | Jyoti Madhusoodanan

More than 50 years after its discovery, CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and its family members, known as CEA-related cell adhesion molecules (CEACAMs), have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.

Core Connection: Analytical Pharmacology

February 2, 2018 | Katie Neith

City of Hope has established a robust drug discovery and development pipeline that provides researchers with all the expertise they need to bring their ideas to reality.

From BMT to CAR T

January 25, 2018 | City of Hope

City of Hope’s history with CAR T cell therapy dates back to the late 1990s and builds on Stephen J. Forman, M.D.’s pioneering work in bone marrow transplantation (BMT).

New Hire: Farah R. Abdulla, M.D.

January 25, 2018 | City of Hope

Farah Abdulla, M.D., specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin.

New Hire: Daniel Jae Kim

January 25, 2018 | City of Hope

Daniel Jae Kim, M.D., is based at City of Hope's South Pasadena facility and specializes in hematology and oncology.

TGen Brings Greater Precision to CAR T Therapies

January 25, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

New Hire: Tanya Dorff, M.D.

January 25, 2018 | City of Hope

Tanya Dorff, M.D., is an associate clinical professor in the Department of Medical Oncology & Therapeutics Research and serves as head of the genitourinary cancers program.

Load More